Advancing Neuroscience with
The University of Cambridge
We have two exciting partnerships with research teams at the University of Cambridge looking at different neurological research. These are:
(1) Neurodegenerative Disease and AI: This partnership focuses on early-stage neurodegenerative disease research by leveraging the University of Cambridge’s fruit fly larva model and the Institut Pasteur’s advanced statistical modelling.
​​
(2) Neurodiversity and Mental Health: Understanding both the diversity within neurodevelopmental conditions and the links to mental health is an urgent and important task. High-quality research can build the evidence-base needed to accelerate diagnosis and improve support, ultimately reducing mortality rates in these vulnerable populations.
Neurodegenerative Disease and AI
Neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, are becoming increasingly prominent in our ageing populations. In recent years, the prevalence of these conditions has been rising dramatically, leading to a significant burden on healthcare systems, families and economies worldwide.
Neurodiversity and Mental Health
Over the last decade, the numbers of individuals who have been diagnosed as neurodiverse have increased. Furthermore, over 70% of individuals with autism or ADHD have a co-occurring mental health condition, and self-harm and death by suicide are sadly, far too common in this group
